Novo Nordisk A/S
CSE:NOVO B
Novo Nordisk A/S
CSE:NOVO B
Price:
894.3 DKK
-0.38%
Updated:
May 2, 2024
Novo Nordisk A/S
Cash from Investing Activities
|
Novo Nordisk A/S
Cash from Investing Activities Peer Comparison
Comparables:
HLUN A
ALK B
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Novo Nordisk A/S
CSE:NOVO B
|
Cash from Investing Activities
-kr43.9B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-32%
|
|
|
H Lundbeck A/S
CSE:HLUN A
|
Cash from Investing Activities
-kr498m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ALK-Abello A/S
CSE:ALK B
|
Cash from Investing Activities
-kr375m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
See Also
What is Novo Nordisk A/S's Cash from Investing Activities?
Cash from Investing Activities
-43.9B
DKK
-43.9B
DKK
Based on the financial report for Dec 31, 2023, Novo Nordisk A/S's Cash from Investing Activities amounts to -43.9B DKK.
What is Novo Nordisk A/S's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-32%
-32%
Over the last year, the Cash from Investing Activities growth was -76%. The average annual Cash from Investing Activities growth rates for Novo Nordisk A/S have been -25% over the past three years , -29% over the past five years , and -32% over the past ten years .
You don't have any saved screeners yet
